NEUROMED PHARMACEUTICALS

neuromed-pharmaceuticals-logo

Neuromed Pharmaceuticals is focused on the development, production, and marketing of pain therapies in Canada and the United States. Neuromed Pharmaceuticals was acquired by Zalicus in December 2009. Neuromed Pharmaceuticals was founded in 1998 and is based in Vancouver, Canada.

#SimilarOrganizations #Financial #Event #Website #More

NEUROMED PHARMACEUTICALS

Industry:
Biopharma Biotechnology Health Care

Founded:
1998-01-01

Address:
Vancouver, British Columbia, Canada

Country:
Canada

Website Url:
http://www.neuromed.com

Total Employee:
11+

Status:
Active

Contact:
(604)909-2530

Total Funding:
136.3 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Content Delivery Network OpenResty AdBlock Acceptable Ads Bodis Bodis DNS


Similar Organizations

celator-pharmaceuticals-logo

Celator Pharmaceuticals

Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.

quadriga-biosciences-logo

Quadriga BioSciences

Quadriga BioSciences is a pharmaceutical company developing proprietary targeted cancer therapies.

Investors List

royal-bank-of-canada_image

RBC Capital

RBC Capital investment in Series E - Neuromed Pharmaceuticals

bdc-venture-capital_image

BDC Venture Capital

BDC Venture Capital investment in Series E - Neuromed Pharmaceuticals

james-richardson-sons_image

James Richardson & Sons

James Richardson & Sons investment in Series E - Neuromed Pharmaceuticals

growthworks_image

GrowthWorks Capital

GrowthWorks Capital investment in Series E - Neuromed Pharmaceuticals

mpm-capital_image

MPM Capital

MPM Capital investment in Series E - Neuromed Pharmaceuticals

bdc-venture-capital_image

BDC Venture Capital

BDC Venture Capital investment in Series D - Neuromed Pharmaceuticals

cogene-ventures_image

Cogene Ventures

Cogene Ventures investment in Series D - Neuromed Pharmaceuticals

royal-bank-of-canada_image

RBC Capital

RBC Capital investment in Series D - Neuromed Pharmaceuticals

mpm-capital_image

MPM Capital

MPM Capital investment in Series D - Neuromed Pharmaceuticals

james-richardson-sons_image

James Richardson & Sons

James Richardson & Sons investment in Series D - Neuromed Pharmaceuticals

Newest Events participated

emtech-asia-2019_event_image Participated in EmTech Asia 2019 on 2019-01-22 as sponsor

Official Site Inspections

http://www.neuromed.com

  • Host name: 199.59.243.227
  • IP address: 199.59.243.227
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Neuromed Pharmaceuticals" on Search Engine